Nuvation Bio Inc.
NUVB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $8 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 10.1% | – | – | – |
| R&D Expenses | $524 | $71 | $88 | $69 |
| G&A Expenses | $67 | $29 | $32 | $24 |
| SG&A Expenses | $69 | $29 | $32 | $24 |
| Sales & Mktg Exp. | $3 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $593 | $100 | $120 | $93 |
| Operating Income | -$593 | -$100 | -$120 | -$93 |
| % Margin | -7,527.3% | – | – | – |
| Other Income/Exp. Net | $25 | $24 | $16 | $6 |
| Pre-Tax Income | -$568 | -$76 | -$104 | -$87 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$568 | -$76 | -$104 | -$87 |
| % Margin | -7,213.8% | – | – | – |
| EPS | -2.11 | -0.35 | -0.48 | -0.44 |
| % Growth | -502.9% | 27.1% | -9.1% | – |
| EPS Diluted | -2.11 | -0.35 | -0.48 | -0.44 |
| Weighted Avg Shares Out | 269 | 219 | 217 | 198 |
| Weighted Avg Shares Out Dil | 269 | 219 | 217 | 198 |
| Supplemental Information | – | – | – | – |
| Interest Income | $27 | $25 | $7 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$567 | -$76 | -$120 | -$93 |
| % Margin | -7,200.7% | – | – | – |